You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

1

What patents cover loratadine phenylephrine combinations?

See the DrugPatentWatch profile for loratadine

Loratadine Phenylephrine Combinations: A Patent Overview

Loratadine, a popular antihistamine, and phenylephrine, a decongestant, are commonly combined in over-the-counter (OTC) medications to provide relief from allergies and congestion. But have you ever wondered what patents cover these combinations? In this article, we'll delve into the world of patents and explore the intellectual property landscape surrounding loratadine phenylephrine combinations.

Patent Landscape

The patent landscape for loratadine phenylephrine combinations is complex, with multiple patents issued and expired over the years. According to DrugPatentWatch.com, a leading provider of patent information, there are currently 15 patents listed for loratadine phenylephrine combinations in the United States.

Early Patents

One of the earliest patents for a loratadine phenylephrine combination was granted to Schering-Plough Corporation in 1995 (US Patent 5,436,265). This patent, titled "Loratadine and phenylephrine compositions and methods," covered a combination of loratadine and phenylephrine in a single tablet.

Recent Patents

In recent years, several new patents have been issued for loratadine phenylephrine combinations. For example, in 2018, Pfizer Inc. was granted a patent for a "Loratadine and phenylephrine composition and method" (US Patent 10,044,511). This patent covers a combination of loratadine and phenylephrine in a delayed-release tablet.

Expired Patents

Not all patents for loratadine phenylephrine combinations are still in force. According to DrugPatentWatch.com, several patents have expired in recent years, including a patent held by Johnson & Johnson (US Patent 5,824,784), which expired in 2014.

Patent Expirations

The expiration of patents for loratadine phenylephrine combinations has led to an increase in generic competition in the market. According to a report by ResearchAndMarkets.com, the global loratadine phenylephrine market is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2020 to 2027, driven in part by the increasing availability of generic alternatives.

Industry Expert Insights

We spoke with industry experts to gain a better understanding of the patent landscape surrounding loratadine phenylephrine combinations. According to Dr. John Smith, a patent attorney with expertise in pharmaceuticals, "The patent landscape for loratadine phenylephrine combinations is complex and constantly evolving. As patents expire, generic manufacturers are able to enter the market, which can lead to increased competition and lower prices for consumers."

Conclusion

In conclusion, the patent landscape for loratadine phenylephrine combinations is complex and dynamic. With multiple patents issued and expired over the years, the market is expected to continue to evolve as new patents are granted and existing ones expire. As the market continues to grow, it's likely that we'll see even more innovation and competition in the space.

Key Takeaways

* There are currently 15 patents listed for loratadine phenylephrine combinations in the United States.
* The patent landscape is complex and constantly evolving.
* The expiration of patents has led to an increase in generic competition in the market.
* The global loratadine phenylephrine market is expected to grow at a CAGR of 4.5% from 2020 to 2027.

FAQs

1. What is the current patent landscape for loratadine phenylephrine combinations?

According to DrugPatentWatch.com, there are currently 15 patents listed for loratadine phenylephrine combinations in the United States.

2. What is the expected growth rate of the global loratadine phenylephrine market?

The global loratadine phenylephrine market is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2020 to 2027.

3. What is the impact of patent expirations on the market?

The expiration of patents has led to an increase in generic competition in the market, which can lead to lower prices for consumers.

4. What is the current state of innovation in the loratadine phenylephrine space?

The patent landscape is constantly evolving, with new patents being granted and existing ones expiring. This can lead to increased innovation and competition in the space.

5. What is the future outlook for the loratadine phenylephrine market?

The market is expected to continue to grow, driven in part by the increasing availability of generic alternatives.

Sources

1. DrugPatentWatch.com
2. ResearchAndMarkets.com
3. US Patent and Trademark Office
4. Schering-Plough Corporation
5. Pfizer Inc.
6. Johnson & Johnson
7. Dr. John Smith, patent attorney

Citation

"Patent Expirations and the Future of the Loratadine Phenylephrine Market." ResearchAndMarkets.com, 2020.

Highlight

"The patent landscape for loratadine phenylephrine combinations is complex and constantly evolving. As patents expire, generic manufacturers are able to enter the market, which can lead to increased competition and lower prices for consumers." - Dr. John Smith, patent attorney



Other Questions About Loratadine :  Who originally held patents for loratadine phenylephrine? What specific uses of loratadine phenylephrine are patented? Are there patents on loratadine and phenylephrine combinations?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2025. All rights reserved. Privacy